Compassionate and scientifically valid treatments for complex, severe and difficult-to-treat mental disorders developed, evaluated and made available for dissemination.
The BRTC develops and evaluates new treatments for difficult-to-treat individuals with severe and complex disorders of pervasive emotion dysregulation. The BRTC is particularly committed to developing effective treatments for those patients excluded from behavioral and medication clinical treatment trials due to high risk for suicide, the complexity of multiple co-occurring disorders and/or history of failure in previous clinical interventions.
The BRTC provides training at all levels to support both new and senior scientists to conduct research aimed at developing and evaluating treatments for these difficult-to-treat individuals. The BRTC is committed to working with undergraduate students to develop research interests and knowledge about working with difficult-to-treat patients, graduate students and post-doctoral fellows to develop the clinical and research skills necessary for this work, and senior scientists to provide support and encouragement in continuing to work with very difficult and high risk populations.